American Council of Cannabis Medicine Established Next Frontier Task Force

2.9 min readPublished On: June 23rd, 2022By

WASHINGTON – Today the American Council of Cannabis Medicine (ACCM) announced the formation of the Next Frontier Task Force. The task force is created to bring together stakeholders from medical cannabis, insurance and third party payers to facilitate expanded participation (today where possible and after changes in the federal scheduling). ACCM has been quietly building the professional standards, platforms and connectors to facilitate interactions that mirror today’s professional pharma industry.

“ACCM is at the forefront of advocating for changing medical-cannabis from a Schedule I substance to a Schedule III substance, allowing for professional research, recognized studies, appropriate oversight and normalization of medical cannabis, similar to any recognized medical therapy.” says, Mark Block, Co-Chair of ACCM’s Legislative Committee. “ACCM as a forward thinking group, has aligned the appropriate partners and thought leaders to facilitate the nuts and bolts making the relationships between third parties and the industry possible. These professionals working together will lead to common sense solutions.”


As the premiere industry organization, ACCM has been able to foster the expert participation, and align the leading edge partners necessary to set the stage for this next phase. ACCM decided that standardizing the mechanics first, made total sense. Today just a small portion of our capabilities are used in operation of our Elevated States program, but we can accommodate complete transition to the next model.

Block added, “It’s amazing to realize that ACCM has standardized the same processes found in mainstream pharmacy today.”

Being mechanically ready for the transition makes it very easy to discuss what needs to happen to take things to the next level. The New Frontier Task Force will focus on the steps necessary to expand patient access through third party payment for medical cannabis, both today, where legal and when fully legal. Medical Cannabis Industry or Insurance/Third Party Industry participants can learn more at:

“Creation of the task force aligns multiple initiatives that ACCM has been working on for years. Building out the programming, infrastructure and standardization to facilitate interaction between dispensaries and pharmacies and third party groups has been a big task, but is critically vital for the transition of the industry,” say’s Greg Zappala Co-Chair of ACCM’s Professional Transition Committee and Next Frontier Task Force Leader. “With multiple state programs and heightened interest by insurance and third party pay groups, alignment makes total sense. Fortunately, our systems and infrastructure are built for now, but more importantly can handle all transformation after federal rescheduling, thus moving us toward a more traditional pharma model. Bringing everyone to the table to participate/facilitate this transition is monumental.”

The American Council of Cannabis Medicine is the “Voice of American Medical Cannabis.” ACCM represents America’s medical-cannabis industry, which supports millions of U.S. jobs and is backed by a growing grassroots movement, supporting millions of beneficiaries. Members produce, process, and distribute medical cannabis through state-licensed programs, as well as, supporting companies, healthcare industry, physicians, researchers, health/wellness providers, insurance companies, systems, and patient advocacy groups. They participate in ACCM’s 15 standing area-centric committees. ACCM was started in 2016 as a Capitol Hill working group and has developed into a mission driven 501c4. Our pressing objective is to facilitate legislation that advances medical cannabis at the federal level and improve state access.

(This information is primarily sourced from American Council of Cannabis Medicine.  Highly Capitalized has neither approved nor disapproved the contents of this news release. Read our Disclaimer here).

About the Author: News Team

Newsteam at Highly Capitalized are some of the most experienced writers in cannabis and psychedelics business & finance. We cover capital markets, finance, branding, marketing and everything important in between. Most of all, we follow the money.

Share This Story, Choose Your Platform!

Latest News

  • Financial Result, CBD Skin Care Market, Cannabis Testing Market

Global Cannabis Testing Market Analysis Report 2023-2030

February 4th, 2023|

DUBLIN - Global Cannabis Testing Market to Reach $2.8 Billion by 2030 In the changed post COVID-19 business landscape, the global market for Cannabis Testing estimated at US$1.1 Billion in the year 2022, is projected to reach ...